NODE 301 PSVT
NODE 301 PSVT: The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an outpatient setting. The secondary objective of this study is to evaluate the safety of etripamil NS 70 mg when administered without medical supervision
COMING SOON!
Primary Investigator: Sean Mazer, MD, FHRS, FACC Sub-Investigators: Michael Bestawros, MD, MPH Yaw Adjei-Poku, MD Brad Gwyther, MS, PA-C Laura McDermott, CNP, MSN, CACP